1. SandlerRS, StewartWF, LibermanJN, et al.Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci2000;45:1166. CrossRef

2. ChoungRS, LockeGR3rd, SchleckCD, et al.The effects of ageing on the onset and disappearance of unexplained abdominal pain: a population‐based study. Aliment Pharmacol Ther2014;39:217. CrossRef

3. PeeryAF, DellonES, LundJ, et al.Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology2012;143:1179. CrossRef

4. MyerPA, MannalitharaA, SinghG, et al.Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States. Am J Gastroenterol2013;108:1496. CrossRef

5. SheridanWG, WhiteAT, HavardT, et al.Non‐specific abdominal pain: the resource implications. Ann R Coll Surg Engl1992;74:181.

6. NyropKA, PalssonOS, LevyRL, et al.Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther2007;26:237. CrossRef

7. HalderSLS, LockeIIIGR. Epidemiology and socioeconomic impact of visceral and abdominal pain syndromes. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 11.

8. SpiegelB, SchoenfeldP, NaliboffB. Systematic review: the prevalence of suicidal behaviour in patients with chronic abdominal pain and irritable bowel syndrome. Aliment Pharmacol Ther2007;26:183. CrossRef

9. KnowlesCH, AzizQ. Basic and clinical aspects of gastrointestinal pain. Pain2009;141:191. CrossRef

10. WillisW, Al‐ChaerE, QuastM, et al.A visceral pain pathway in the dorsal column of the spinal cord. Proc Natl Acad Sci U S A1999;96:7675. CrossRef

11. PalecekJ. The role of dorsal columns pathway in visceral pain. Physiol Res2004;53(Suppl. 1):S125.

12. Al‐ChaerED, FengY, WillisWD. A role for the dorsal column in nociceptive visceral input into the thalamus of primates. J Neurophysiol1998;79:3143.

13. StrigoIA, DuncanGH, BushnellMC, et al.The effects of racemic ketamine on painful stimulation of skin and viscera in human subjects. Pain2005;113:255. CrossRef

14. CraigAD. Pain mechanisms: labeled lines versus convergence in central processing. Annu Rev Neurosci2003;26:1. CrossRef

15. PriceD. Psychological and neural mechanisms of the affective dimension of pain. Science2000;288:1769. CrossRef

16. MayerEA, NaliboffBD, CraigAD. Neuroimaging of the brain‐gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology2006;131:1925. CrossRef

17. WillisW, WestlundK. Neuroanatomy of the pain system and the pathways that modulate pain. J Clin Neurophysiol1997;40:968.

18. RussoCM, BroseWG. Chronic pain. Annu Rev Med1998;49:123. CrossRef

19. LoeserJD. Pain and suffering. Clin J Pain2000;16:S2. CrossRef

20. TurkDC, OkifujiA. Does sex make a difference in the prescription of treatments and the adaptation to chronic pain by cancer and non‐cancer patients?Pain1999;82:139. CrossRef

21. LevyRL, OldenKW, NaliboffBD, et al.Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology2006;130:1447. CrossRef

22. Al‐ChaerED, WillisWD. Neuroanatomy of visceral pain: pathways and processes. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 33.

23. BrierlySM, BlackshawLA. The neurobiology of visceral nociceptors. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic abdominal and visceral pain: theory and practice, 1st edn. New York and London: Informa Healthcare, 2007: 45.

24. MaW, QuirionR. Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets2007;11:307. CrossRef

25. PingleSC, MattaJA, AhernGP. Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb Exp Pharmacol2007;179:155. CrossRef

26. SzallasiA, CortrightDN, BlumCA, et al.The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof‐of‐concept. Nat Rev Drug Discov2007;6:357. CrossRef

27. BielefeldtK. Neurochemical and molecular basis of peripheral sensitization. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 67.

28. WoolfCJ, SalterMW. Neuronal plasticity: increasing the gain in pain. Science2000;288:1765. CrossRef

29. BrazJM, NassarMA, WoodJN, et al.Parallel “pain” pathways arise from subpopulations of primary afferent nociceptor. Neuron2005;47:787. CrossRef

30. SniderWD, McMahonSB. Tackling pain at the source: new ideas about nociceptors. Neuron1998;20:629. CrossRef

31. ZeilhoferHU. The glycinergic control of spinal pain processing. Cell Mol Life Sci2005;62:2027. CrossRef

32. EnnaSJ, McCarsonKE. The role of GABA in the mediation and perception of pain. Adv Pharmacol2006;54:1. CrossRef

33. KirschJ. Glycinergic transmission. Cell Tissue Res2006;326:535. CrossRef

34. SommerC. Is serotonin hyperalgesic or analgesic?Curr Pain Headache Rep2006;10:101. CrossRef

35. PertovaaraA. Noradrenergic pain modulation. Prog Neurobiol2006;80:53. CrossRef

36. NessTJ. DIstinctive clinical and biological characteristics of visceral pain. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 1.

37. StrigoIA, BushnellMC, BoivinM, et al.Psychophysical analysis of visceral and cutaneous pain in human subjects. Pain2002;97:235. CrossRef

38. RajP. Visceral pain. In: RajP(ed). Practical Management of Pain. St Louis: Mosby, 2000: 145.

39. SnellRS. Clinical Anatomy for Medical Students, 6th edn. Philadelphia: Lippincott, Williams & Wilkins, 2000.

40. GiamberardinoMA, CerveroF. The neural basis of referred visceral pain. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 177.

41. ChristiansonJA, LiangR, UstinovaEE, et al.Convergence of bladder and colon sensory innervation occurs at the primary afferent level. Pain2007;128:235. CrossRef

42. TattersallJE, CerveroF, LumbBM. Viscerosomatic neurons in the lower thoracic spinal cord of the cat: excitations and inhibitions evoked by splanchnic and somatic nerve volleys and by stimulation of brain stem nuclei. J Neurophysiol1986;56:1411.

43. GiamberardinoMA, AffaitatiG, LerzaR, et al.Evaluation of indices of skeletal muscle contraction in areas of referred hyperalgesia from an artificial ureteric stone in rats. Neurosci Lett2003;338:213. CrossRef

44. GiamberardinoMA, DalalA, ValenteR, et al.Changes in activity of spinal cells with muscular input in rats with referred muscular hyperalgesia from ureteral calculosis. Neurosci Lett1996;203:89. CrossRef

45. MalykhinaAP, QinC, Greenwood‐van MeerveldB, et al.Hyperexcitability of convergent colon and bladder dorsal root ganglion neurons after colonic inflammation: mechanism for pelvic organ cross‐talk. Neurogastroenterol Motil2006;18:936. CrossRef

46. MalykhinaAP, QinC, ForemanRD, et al.Colonic inflammation increases Na+ currents in bladder sensory neurons. Neuroreport2004;15:2601. CrossRef

47. CerveroF, LairdJM. Visceral pain.Lancet1999;353:2145. CrossRef

48. DrayA. Inflammatory mediators of pain. Br J Anaesth1995;75:125. CrossRef

49. WoolfCJ, CostiganM. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A1999;96:7723. CrossRef

50. DupontAW, PasrichaPJ. Irritable bowel syndrome and functional abdominal pain syndromes: pathophysiology. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 33.

51. YiangouY, FacerP, DyerNH, et al.Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet2001;357:1338. CrossRef

52. ChanCL, FacerP, DavisJB, et al.Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet2003;361:385. CrossRef

53. MatthewsPJ, AzizQ, FacerP, et al.Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol2004;16:897. CrossRef

54. BuchlerM, WeiheE, FriessH, et al.Changes in peptidergic innervation in chronic pancreatitis. Pancreas1992;7:183. CrossRef

55. ShrikhandeSV, FriessH, di MolaFF, et al.NK‐1 receptor gene expression is related to pain in chronic pancreatitis. Pain2001;91:209. CrossRef

56. ZhuZW, FriessH, WangL, et al.Brain‐derived neurotrophic factor (BDNF) is upregulated and associated with pain in chronic pancreatitis. Dig Dis Sci2001;46:1633. CrossRef

57. FriessH, ZhuZ, di MolaF, et al.Nerve growth factor and its high‐affinity receptor in chronic pancreatitis. Ann Surg1999;230:215. CrossRef

58. BuscherHC, Wilder‐SmithOH, van GoorH. Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study. Eur J Pain2006;10:363. CrossRef

59. DimcevskiG, SamiSA, Funch‐JensenP, et al.Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology2007;132:1546. CrossRef

60. OlesenSS, FrokjaerJB, LelicD, et al.Pain‐associated adaptive cortical reorganisation in chronic pancreatitis. Pancreatology2010;10:742. CrossRef

61. OlesenSS, HansenTM, GraversenC, et al.Slowed EEG rhythmicity in patients with chronic pancreatitis: evidence of abnormal cerebral pain processing?Eur J Gastroenterol Hepatol2011;23:418. CrossRef

62. FrokjaerJB, OlesenSS, GramM, et al.Altered brain microstructure assessed by diffusion tensor imaging in patients with chronic pancreatitis. Gut2011;60:1554. CrossRef

63. BouwenseSA, BuscherHC, van GoorH, et al.S‐ketamine modulates hyperalgesia in patients with chronic pancreatitis pain. Reg Anesth Pain Med2011;36:303. CrossRef

64. CerveroF. Visceral pain: mechanisms of peripheral and central sensitization. Ann Med1995;27:235. CrossRef

65. CamilleriM, FordMJ. Review article: colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Aliment Pharmacol Ther1998;12:287. CrossRef

66. RhodesDY, WallaceM. Post‐infectious irritable bowel syndrome. Curr Gastroenterol Rep2006;8:327. CrossRef

67. BuscherHC, van GoorH, Wilder‐SmithOH. Effect of thoracoscopic splanchnic denervation on pain processing in chronic pancreatitis patients. Eur J Pain2007;11:437. CrossRef

68. EisenachJC, CarpenterR, CurryR. Analgesia from a peripherally active kappa‐opioid receptor agonist in patients with chronic pancreatitis. Pain2003;101:89. CrossRef

69. HongJY, LabusJS, JiangZ, et al.Regional neuroplastic brain changes in patients with chronic inflammatory and non‐inflammatory visceral pain. PLoS ONE2014;9:e84564. CrossRef

70. NaliboffBD, MayerEA. Brain imaging in IBS: drawing the line between cognitive and non‐cognitive processes. Gastroenterology2006;130:267. CrossRef

71. CoutinhoSV, PlotskyPM, SabladM, et al.Neonatal maternal separation alters stress‐induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol2002;282:G307. CrossRef

72. MayerEA, NaliboffBD, ChangL, et al.V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol2001;280:G519.

73. TacheY, PerdueMH. Role of peripheral CRF signalling pathways in stress‐related alterations of gut motility and mucosal function. Neurogastroenterol Motil2004;16(Suppl. 1):137. CrossRef

74. FukudoS, SaitoK, SagamiY, et al.Can modulating corticotropin releasing hormone receptors alter visceral sensitivity?Gut2006;55:146. CrossRef

75. LiuL, LiQ, SapolskyR, et al.Transient gastric irritation in the neonatal rats leads to changes in hypothalamic CRF expression, depression‐ and anxiety‐like behavior as adults. PLoS ONE2011;6:e19498. CrossRef

76. BravoJA, ForsytheP, ChewMV, et al.Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A2011;108:16050. CrossRef

77. BercikP, VerduEF, FosterJA, et al.Chronic gastrointestinal inflammation induces anxiety‐like behavior and alters central nervous system biochemistry in mice. Gastroenterology2010;139:2102. CrossRef

78. KoloskiNA, JonesM, KalantarJ, et al.The brain – gut pathway in functional gastrointestinal disorders is bidirectional: a 12‐year prospective population‐based study. Gut2012;61:1284. CrossRef

79. DerasariM. Taxonomy of pain syndromes: classification of chronic pain syndromes. In: RajPP(ed.). Practical Management of Pain, 3rd edn. St. Louis: CV Mosby, 2000: 10.

80. CerveroF. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev1994;74:95.

81. NessTJ, GebhartGF. Visceral pain: a review of experimental studies. Pain1990;41:167. CrossRef

82. NessT, MetcalfA, GebhartG. A psychophysiological study in humans using phasic colonic distension as a noxious visceral stimulus. Pain1990;43:377. CrossRef

83. DavisMP. Drug management of visceral pain: concepts from basic research. Pain Res Treat2012;2012:265605.

84. FrenchE, RobbW. Biliary and renal colic. Br Med J1963;2:135. CrossRef

85. HorrocksJ, De DombalF. Clinical presentation of patients with ‘dyspepsia.’ Detailed symptomatic study of 360 patients. Gut1978;19:19. CrossRef

86. WoodsworthR, SherringtonC. A pseudoaffective reflex and its spinal path. J Physiol (Lond)1904;31:234. CrossRef

87. LiddingtonMI, ThomsonWH. Rebound tenderness test. Br J Surg1991;78:795. CrossRef

88. ThomsonH, FrancisDM. Abdominal‐wall tenderness: a useful sign in the acute abdomen. Lancet1977;2:1053. CrossRef

89. ThomsonWH, DawesRF, CarterSS. Abdominal wall tenderness: a useful sign in chronic abdominal pain. Br J Surg1991;78:223. CrossRef

90. ChiarioniG, AsteriaC, WhiteheadWE. Chronic proctalgia and chronic pelvic pain syndromes: new etiologic insights and treatment options. World J Gastroenterol2011;17:4447. CrossRef

91. RoyS, WeimersheimerP. Nonoperative causes of abdominal pain.Surg Clin North Am1997;77:1433. CrossRef

92. LongstrethGF, NewcomerAD. Abdominal pain caused by diabetic radiculopathy. Ann Intern Med1977;86:166. CrossRef

93. LongstrethGF. Diabetic thoracic polyradiculopathy: ten patients with abdominal pain. Am J Gastroenterol1997;92:502.

94. LongstrethGF. Diabetic thoracic polyradiculopathy. Best Pract Res Clin Gastroenterol2005;19:275. CrossRef

95. ZackowskiSW. Chronic recurrent abdominal pain. Emerg Med Clin North Am1998;16:877. CrossRef

96. StevensonRJ. Abdominal pain unrelated to trauma. Surg Clin North Am1985;65:1181.

97. BlendisL. Abdominal pain. In: WallP, MelzackR(eds). Textbook of Pain. 3rd edn. London: Churchill Livingstone, 1994: 583.

98. DrossmanDA. The patient with chronic undiagnosed abdominal pain. Hosp Pract (Off Ed)1986;21:24, 29.

99. BardanE, NadlerM, ChowersY, et al.Capsule endoscopy for the evaluation of patients with chronic abdominal pain. Endoscopy2003;35:688. CrossRef

100. FryLC, CareyEJ, ShiffAD, et al.The yield of capsule endoscopy in patients with abdominal pain or diarrhea. Endoscopy2006;38:498. CrossRef

101. MayA, MannerH, SchneiderM, et al.Prospective multicenter trial of capsule endoscopy in patients with chronic abdominal pain, diarrhea and other signs and symptoms (CEDAP‐Plus Study). Endoscopy2007;39:606. CrossRef

102. PashaSF, FleischerDE. Capsule endoscopy for abdominal pain – is it of value or just another test for doctors to do?Endoscopy2007;39:650. CrossRef

103. SpadaC, PirozziGA, RiccioniME, et al.Capsule endoscopy in patients with chronic abdominal pain. Dig Liver Dis2006;38:696. CrossRef

104. CamilleriM. Management of the patient with chronic abdominal pain and clinical pharmacology of nonopioid drugs. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 271.

105. RuddellWS, LintottDJ, AxonAT. The diagnostic yield of ERCP in the investigation of unexplained abdominal pain. Br J Surg1983;70:74. CrossRef

106. OldenKW. Rational management of chronic abdominal pain. Compr Ther1998;24:180.

107. EasterDW, CuschieriA, NathansonLK, et al.The utility of diagnostic laparoscopy for abdominal disorders. Audit of 120 patients. Arch Surg1992;127:379. CrossRef

108. WeibelM. Peritoneal adhesions and their relation to abdominal surgery. Am J Surg1973;126:345. CrossRef

109. RapkinA. Adhesions and pelvic pain: a retrospective study. Obstet Gynecol1986;68:13.

110. SwankDJ, Swank‐BordewijkSC, HopWC, et al.Laparoscopic adhesiolysis in patients with chronic abdominal pain: a blinded randomised controlled multi‐centre trial. Lancet2003;361:1247. CrossRef

111. SwankDJ, Van ErpWF, Repelaer Van DrielOJ, et al.A prospective analysis of predictive factors on the results of laparoscopic adhesiolysis in patients with chronic abdominal pain. Surg Laparosc Endosc Percutan Tech2003;13:88. CrossRef

112. LoVecchioF, OsterN, SturmannK, et al.The use of analgesics in patients with acute abdominal pain. J Emerg Med1997;15:775. CrossRef

113. BackonjaM. Neuromodulating drugs for the symptomatic treatment of neuropathic pain. Curr Pain Headache Rep2004;8:212. CrossRef

114. DrossmanDA, TonerBB, WhiteheadWE, et al.Cognitive‐behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology2003;125:19. CrossRef

115. SuX, GebhartGF. Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon. Pain1998;76:105. CrossRef

116. MaysTA. Antidepressants in the management of cancer pain. Curr Pain Headache Rep2001;5:227. CrossRef

117. RuepertL, QuarteroAO, de WitNJ, et al.Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev2011;CD003460.

118. TurkDC, OkifujiA. Pain: assessment of patients' reporting of pain: an integrated perspective. Lancet1999;353:1784. CrossRef

119. SperberAD, DrossmanDA. Review article: the functional abdominal pain syndrome. Aliment Pharmacol Ther2011;33:514. CrossRef

120. O'ConnorAB, DworkinRH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med2009;122:S22.

121. van KerkhovenLA, LaheijRJ, AparicioN, et al.Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double‐blind, placebo‐controlled trial. Clin Gastroenterol Hepatol2008;6:746, quiz 718. CrossRef

122. ChialHJ, CamilleriM, FerberI, et al.Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol2003;1:211. CrossRef

123. KaplanA, FranzenMD, NickellPV, et al.An open‐label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder. Int J Psychiatry Clin Pract2014;18:11. CrossRef

124. BrennanBP, FogartyKV, RobertsJL, et al.Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot study. Hum Psychopharmacol2009;24:423. CrossRef

125. NakaiK, NakaeA, HashimotoR, et al.Antinociceptive effects of mirtazapine, pregabalin, and gabapentin after chronic constriction injury of the infraorbital nerve in rats. J Oral Facial Pain Headache2014;28:61. CrossRef

126. YinJ, SongJ, LeiY, et al.Prokinetic effects of mirtazapine on gastrointestinal transit. Am J Physiol Gastrointest Liver Physiol2014;306:G796. CrossRef

127. ColuzziF, MattiaC. Mechanism‐based treatment in chronic neuropathic pain: the role of antidepressants. Curr Pharm Des2005;11:2945. CrossRef

128. MicoJA, ArdidD, BerrocosoE, et al.Antidepressants and pain. Trends Pharmacol Sci2006;27:348. CrossRef

129. SaartoT, WiffenPJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev2005;CD005454.

130. SindrupSH, OttoM, FinnerupNB, et al.Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol2005;96:399. CrossRef

131. ClouseRE, LustmanPJ, EckertTC, et al.Low‐dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double‐blind, placebo‐controlled trial. Gastroenterology1987;92:1027.

132. TackJ, JanssenP, MasaokaT, et al.Efficacy of buspirone, a fundus‐relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol2012;10:1239. CrossRef

133. GroverM, DornSD, WeinlandSR, et al.Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders. Dig Dis Sci2009;54:1284. CrossRef

134. Tremont‐LukatsIW, MegeffC, BackonjaMM. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs2000;60:1029. CrossRef

135. MagnusL. Nonepileptic uses of gabapentin. Epilepsia1999;40(Suppl. 6):S66, discussion S73‐4. CrossRef

136. HoughtonLA, FellC, WhorwellPJ, et al.Effect of a second‐generation alpha2delta ligand, Pregabalin on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut2007;56:1218. CrossRef

137. DiopL, RaymondF, FargeauH, et al.Pregabalin (CI‐1008) inhibits the trinitrobenzene sulfonic acid‐induced chronic colonic allodynia in the rat. J Pharmacol Exp Ther2002;302:1013. CrossRef

138. FengY, CuiM, WillisWD. Gabapentin markedly reduces acetic acid‐induced visceral nociception. Anesthesiology2003;98:729. CrossRef

139. LeeKJ, KimJH, ChoSW. Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea‐predominant irritable bowel syndrome. Aliment Pharmacol Ther2005;22:981. CrossRef

140. SmileyMM, LuY, Vera‐PortocarreroLP, et al.Intrathecal gabapentin enhances the analgesic effects of subtherapeutic dose morphine in a rat experimental pancreatitis model. Anesthesiology2004;101:759. CrossRef

141. MillionM, WangL, AdelsonDW, et al.Pregabalin decreases visceral pain and prevents spinal neuronal activation in rats. Gut2007;56:1482. CrossRef

142. OlesenSS, BouwenseSA, Wilder‐SmithOH, et al.Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology2011;141:536. CrossRef

143. OlesenSS, GraversenC, OlesenAE, et al.Randomised clinical trial: pregabalin attenuates experimental visceral pain through sub‐cortical mechanisms in patients with painful chronic pancreatitis. Aliment Pharmacol Ther2011;34:878. CrossRef

144. RavnefjordA, BrusbergM, LarssonH, et al.Effects of pregabalin on visceral pain responses and colonic compliance in rats. Br J Pharmacol2008;155:407. CrossRef

145. Shamsi MeymandiM, KeyhanfarF. Relative potency of pregabalin, gabapentin, and morphine in a mouse model of visceral pain. Can J Anaesth2013;60:44. CrossRef

146. WiffenPJ, DerryS, MooreRA, et al.Antiepileptic drugs for neuropathic pain and fibromyalgia – an overview of Cochrane reviews. Cochrane Database Syst Rev2013;(11):CD010567.

147. BallantyneJC. Pharmacology and practice of opioid drugs for visceral pain. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 287.

148. ThompsonD. Narcotic analgesic effects on the Sphincter of Odd: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol2001;96:1266. CrossRef

149. RuskisA. Effects of narcotics on gastrointestinal tract, liver and kidneys. In: KitahataL, CollinsJ(eds). Narcotic Analgesics in Anesthesiology. Baltimore: Williams and Wilkins, 1982: 143.

150. RaffaRB, PergolizziJVJr. Opioid‐induced hyperalgesia: is it clinically relevant for the treatment of pain patients?Pain Manag Nurs2013;14:e67. CrossRef

151. JohnsonJL, HutchinsonMR, WilliamsDB, et al.Medication‐overuse headache and opioid‐induced hyperalgesia: a review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment. Cephalalgia2013;33:52. CrossRef

152. HendlerN. Pharmacological Management of Pain. In: RajPP(ed.). Practical Management of Pain. St Louis: Mosby, 2000: 145.

153. GourlayGK. Clinical pharmacology of the treatment of choronic non‐cancer pain. In: DevorM; IASP Scientific Program Committee(eds).Pain 1999 – an Updated Review. Seattle: IASP Press, 1999: 433.

154. RaffaRB, BuschmannH, ChristophT, et al.Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opin Pharmacother2012;13:1437. CrossRef

155. RadbruchL, GlaeskeG, GrondS, et al.Topical review on the abuse and misuse potential of tramadol and tilidine in Germany. Subst Abus2013;34:313. CrossRef

156. Wilder‐SmithCH, HillL, WilkinsJ, et al.Effects of morphine and tramadol on somatic and visceral sensory function and gastrointestinal motility after abdominal surgery. Anesthesiology1999;91:639. CrossRef

157. KwongWJ, HammondG, UpmalisD, et al.Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain. Clin J Pain2013;29:664. CrossRef

158. TzschentkeTM, JahnelU, KogelB, et al.Tapentadol hydrochloride: a next‐generation, centrally acting analgesic with two mechanisms of action in a single molecule. Drugs Today (Barc)2009;45:483.

159. CheyWD, BeydounA, RobertsDJ, et al.Octreotide reduces perception of rectal electrical stimulation by spinal afferent pathway inhibition. Am J Physiol1995;269:G821.

160. BradetteM, DelvauxM, StaumontG, et al.Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone. Dig Dis Sci1994;39:1171. CrossRef

161. HaslerWL, SoudahHC, OwyangC. A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention. Gastroenterology1993;104:1390.

162. HaslerWL, SoudahHC, OwyangC. Somatostatin analog inhibits afferent response to rectal distention in diarrhea‐predominant irritable bowel patients. J Pharmacol Exp Ther1994;268:1206.

163. CamilleriM, KimDY, McKinzieS, et al.A randomized, controlled exploratory study of clonidine in diarrhea‐predominant irritable bowel syndrome. Clin Gastroenterol Hepatol2003;1:111. CrossRef

164. KuikenSD, LeiA, TytgatGN, et al.Effect of the low‐affinity, noncompetitive N‐methyl‐d‐aspartate receptor antagonist dextromethorphan on visceral perception in healthy volunteers. Aliment Pharmacol Ther2002;16:1955. CrossRef

165. FisherK, CoderreTJ, HagenNA. Targeting the N‐methyl‐D‐aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage2000;20:358. CrossRef

166. Ben‐AriA, LewisMC, DavidsonE. Chronic administration of ketamine for analgesia. J Pain Palliat Care Pharmacother2007;21:7. CrossRef

167. ChizhBA. Low dose ketamine: a therapeutic and research tool to explore N‐methyl‐D‐aspartate (NMDA) receptor‐mediated plasticity in pain pathways. J Psychopharmacol2007;21:259. CrossRef

168. MillerMA, HarrisonBP. Ketamine: it is not just for kids anymore. Am J Emerg Med2007;25:725. CrossRef

169. OkonT. Ketamine: an introduction for the pain and palliative medicine physician. Pain Physician2007;10:493.

170. HoganQH, AbramSE. Neural blockade for diagnosis and prognosis. A review. Anesthesiology1997;86:216. CrossRef

171. MercadanteS, NicosiaF. Celiac plexus block: a reappraisal. Reg Anesth Pain Med1998;23:37.

172. PattR. Outcomes, efficacy, complications, and sequelae of visceral pain management. In: RajPP(ed.). Practical Pain Management. St. Louis: Mosby, 2000: 904.

173. Ver DonckA, VrankenJH, PuylaertM, et al.Intrathecal drug administration in chronic pain syndromes. Pain Pract2014;14:461.

174. GadsbyJG, FlowerdewMW. Transcutaneous electrical nerve stimulation and acupuncture‐like transcutaneous electrical nerve stimulation for chronic low back pain. Cochrane Database Syst Rev2000;CD000210.

175. BorjessonM, PilhallM, EliassonT, et al.Esophageal visceral pain sensitivity: effects of TENS and correlation with manometric findings. Dig Dis Sci1998;43:1621. CrossRef

176. KapurS, MutagiH, RaphaelJ. Spinal cord stimulation for relief of abdominal pain in two patients with familial Mediterranean fever. Br J Anaesth2006;97:866. CrossRef

177. KapuralL, NarouzeSN, JanickiTI, et al.Spinal cord stimulation is an effective treatment for the chronic intractable visceral pelvic pain. Pain Med2006;7:440. CrossRef

178. PatriziF, FreedmanSD, Pascual‐LeoneA, et al.Novel therapeutic approaches to the treatment of chronic abdominal visceral pain. Scientificworldjournal2006;6:472. CrossRef

179. TiedeJM, GhaziSM, LamerTJ, et al.The use of spinal cord stimulation in refractory abdominal visceral pain: case reports and literature review. Pain Pract2006;6:197. CrossRef

180. BaranidharanG, SimpsonKH, DhandapaniK. Spinal cord stimulation for visceral pain – a novel approach. Neuromodulation2014;17:753. CrossRef

181. KapuralL, CywinskiJB, SparksDA. Spinal cord stimulation for visceral pain from chronic pancreatitis. Neuromodulation2011;14:423, discussion 426‐7. CrossRef

182. KapuralL, DeerT, YakovlevA, et al.Technical aspects of spinal cord stimulation for managing chronic visceral abdominal pain: the results from the national survey. Pain Med2010;11:685. CrossRef

183. KapuralL, NagemH, TlucekH, et al.Spinal cord stimulation for chronic visceral abdominal pain. Pain Med2010;11:347. CrossRef

184. KimJK, HongSH, KimMH, et al.Spinal cord stimulation for intractable visceral pain due to chronic pancreatitis. J Korean Neurosurg Soc2009;46:165. CrossRef

185. VerganiF, BoukasA, MukerjiN, et al.Spinal cord stimulation for visceral pain related to chronic pancreatitis: report of 2 cases. World Neurosurg2014;81:651 e17. CrossRef

186. BrookerCD, CousinsMJ. Neuromodulation techniques for visceral pain from benign disorders. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 311.

187. DuHJ, ChaoYF. Localization of central structures involved in descending inhibitory effect of acupuncture on viscero‐somatic reflex discharges. Sci Sin1976;19:137.

188. ShuJ, LiKY, HuangDK. The central effect of electro‐acupuncture analgesia on visceral pain of rats: a study using the [3H] 2‐deoxyglucose method. Acupunct Electrother Res1994;19:107.

189. RongPJ, ZhuB, HuangQF, et al.Acupuncture inhibition on neuronal activity of spinal dorsal horn induced by noxious colorectal distention in rat. World J Gastroenterol2005;11:1011. CrossRef

190. LimB, ManheimerE, LaoL, et al.Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev2006;CD005111.

191. TakahashiT. Acupuncture for functional gastrointestinal disorders. J Gastroenterol2006;41:408. CrossRef

192. SierpinaVS, KuncharapuI. Complementary and integrative medicine approaches to visceral pain. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 33.

193. FordAC, QuigleyEM, LacyBE, et al.Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta‐analysis. Am J Gastroenterol2014;109:1350. CrossRef

194. LeeHH, ChoiYY, ChoiMG. The efficacy of hypnotherapy in the treatment of irritable bowel syndrome: a systematic review and meta‐analysis. J Neurogastroenterol Motil2014;20:152. CrossRef

195. RuttenJM, ReitsmaJB, VliegerAM, et al.Gut‐directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review. Arch Dis Child2013;98:252. CrossRef

196. WebbAN, KukuruzovicRH, Catto‐SmithAG, et al.Hypnotherapy for treatment of irritable bowel syndrome. Cochrane Database Syst Rev2007;CD005110.

197. WilsonS, MaddisonT, RobertsL, et al.Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome. Aliment Pharmacol Ther2006;24:769. CrossRef

198. SuleimanS, JohnstonDE. The abdominal wall: an overlooked source of pain. Am Fam Physician2001;64:431.

199. GreenbaumDS. Abdominal wall pain. In: PasrichaPJ, WillisWD, GebhartGF(eds). Chronic Abdominal and Visceral Pain: Theory and Practice, 1st edn. New York: Informa, 2007: 427.

200. CostanzaCD, LongstrethGF, LiuAL. Chronic abdominal wall pain: clinical features, health care costs, and long‐term outcome. Clin Gastroenterol Hepatol2004;2:395. CrossRef

201. SrinivasanR, GreenbaumDS. Chronic abdominal wall pain: a frequently overlooked problem. Practical approach to diagnosis and management. Am J Gastroenterol2002;97:824.

202. ApplegateWV, BuckwalterNR. Microanatomy of the structures contributing to abdominal cutaneous nerve entrapment syndrome. J Am Board Fam Pract1997;10:329.

203. GallegosN, HobsleyM. Abdominal pain: parietal or visceral?J R Soc Med1992;85:379.

204. GrayDW, DixonJM, SeabrookG, et al.Is abdominal wall tenderness a useful sign in the diagnosis of non‐specific abdominal pain?Ann R Coll Surg Engl1988;70:233.

205. GreenbaumDS, GreenbaumRB, JosephJG, et al.Chronic abdominal wall pain. Diagnostic validity and costs. Dig Dis Sci1994;39:1935. CrossRef

206. GallegosNC, HobsleyM. Abdominal wall pain: an alternative diagnosis. Br J Surg1990;77:1167. CrossRef

207. BoelensOB, ScheltingaMR, HoutermanS, et al.Randomized clinical trial of trigger point infiltration with lidocaine to diagnose anterior cutaneous nerve entrapment syndrome. Br J Surg2013;100:217. CrossRef

208. ScheltingaMR, BoelensOB, TjonATWE, et al.Surgery for refractory anterior cutaneous nerve entrapment syndrome (ACNES) in children. J Pediatr Surg2011;46:699. CrossRef

209. BoelensOB, van AssenT, HoutermanS, et al.A double‐blind, randomized, controlled trial on surgery for chronic abdominal pain due to anterior cutaneous nerve entrapment syndrome. Ann Surg2013;257:845. CrossRef

210. KamanliA, KayaA, ArdicogluO, et al.Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int2005;25:604. CrossRef

211. AffaitatiG, FabrizioA, SaviniA, et al.A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther2009;31:705. CrossRef

212. ClouseRE, MayerEA, AzizQ, et al.Functional abdominal pain syndrome. Gastroenterology2006;130:1492. CrossRef

213. LongstrethGF, DrossmanDA. Severe irritable bowel and functional abdominal pain syndromes: managing the patient and health care costs. Clin Gastroenterol Hepatol2005;3:397. CrossRef

214. SperberAD, DrossmanDA. Functional abdominal pain syndrome: constant or frequently recurring abdominal pain. Am J Gastroenterol2010;105:770. CrossRef

215. DrossmanDA, LiZ, AndruzziE, et al.U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci1993;38:1569. CrossRef

216. ThompsonWG, IrvineEJ, PareP, et al.Functional gastrointestinal disorders in Canada: first population‐based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci2002;47:225. CrossRef

217. SperberAD, ShvartzmanP, FrigerM, et al.Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterol Motil2005;17:207. CrossRef

218. DrossmanDA. Chronic functional abdominal pain. Am J Gastroenterol1996;91:2270.

219. HillOW, BlendisL. Physical and psychological evaluation of ‘non‐organic’ abdominal pain. Gut1967;8:221. CrossRef

220. RoseJD, TroughtonAH, HarveyJS, et al.Depression and functional bowel disorders in gastrointestinal outpatients. Gut1986;27:1025. CrossRef

221. MagniG, RossiMR, Rigatti‐LuchiniS, et al.Chronic abdominal pain and depression. Epidemiologic findings in the United States. Hispanic Health and Nutrition Examination Survey. Pain1992;49:77. CrossRef

222. GomezJ, DallyP. Psychologically mediated abdominal pain in surgical and medical outpatients clinics. Br Med J1977;1:1451. CrossRef

223. DrossmanDA, LesermanJ, NachmanG, et al.Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med1990;113:828. CrossRef

224. LawsonMJ, GrantAK, PaullA, et al.Significance of nocturnal abdominal pain: a prospective study. Br Med J1980;280:1302. CrossRef

225. DrossmanDA. Patients with psychogenic abdominal pain: six years' observation in the medical setting. Am J Psychiatry1982;139:1549. CrossRef

226. SlothH, JorgensenLS. Chronic non‐organic upper abdominal pain: diagnostic safety and prognosis of gastrointestinal and non‐intestinal symptoms. A 5‐ to 7‐year follow‐up study. Scand J Gastroenterol1988;23:1275. CrossRef

227. GrayDW, DixonJM, CollinJ. The closed eyes sign: an aid to diagnosing non‐specific abdominal pain. BMJ1988;297:837. CrossRef

228. DevorD, KnauftRD. Exploratory laparotomy for abdominal pain of unknown etiology. Diagnosis, management, and follow‐up of 40 cases. Arch Surg1968;96:836. CrossRef

229. DeVaulRAFL. Persistent pain and illness insistence: a medical profile of proneness to surgery. Am J Surg1978;135:828. CrossRef

230. SarfehIJ. Abdominal pain of unknown etiology. Am J Surg1976;132:22. CrossRef

231. DrossmanDA. Severe and refractory chronic abdominal pain: treatment strategies. Clin Gastroenterol Hepatol2008;6:978. CrossRef